Deborah J. Burt

3.1k total citations
24 papers, 1.6k citations indexed

About

Deborah J. Burt is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Deborah J. Burt has authored 24 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 14 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Deborah J. Burt's work include Immunotherapy and Immune Responses (14 papers), Immune Cell Function and Interaction (8 papers) and T-cell and B-cell Immunology (7 papers). Deborah J. Burt is often cited by papers focused on Immunotherapy and Immune Responses (14 papers), Immune Cell Function and Interaction (8 papers) and T-cell and B-cell Immunology (7 papers). Deborah J. Burt collaborates with scholars based in United Kingdom, Netherlands and Spain. Deborah J. Burt's co-authors include Robert E. Hawkins, Peter L. Stern, Eyad Elkord, Fiona Thistlethwaite, Eric Austin, Dominic G. Rothwell, Christy Ralph, Ged Brady, Louise Carter and Fiona Blackhall and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Deborah J. Burt

24 papers receiving 1.6k citations

Peers

Countries citing papers authored by Deborah J. Burt

Since Specialization

Citations

This map shows the geographic impact of Deborah J. Burt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah J. Burt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah J. Burt more than expected).

Fields of papers citing papers by Deborah J. Burt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah J. Burt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah J. Burt. The network helps show where Deborah J. Burt may publish in the future.

Co-authorship network of co-authors of Deborah J. Burt

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah J. Burt. A scholar is included among the top collaborators of Deborah J. Burt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah J. Burt. Deborah J. Burt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The clinical efficacy of first-generation carcinoembryonic antigen (CEACAM5)-specific CAR T cells is limited by poor persistence and transient pre-conditioning-dependent respiratory toxicity 2017 ·Cancer Immunology Immunotherapy ·Fiona Thistlethwaite, David E. Gilham, Ryan D. Guest, Dominic G. Rothwell, Manon Pillai, Deborah J. Burt, (unknown), Н. А. Кириллова, Juan W. Valle, Surinder K. Sharma, Kerry Chester, Nigel Westwood, Sarah Halford, Stephen Nabarro, Susan Wan, Eric Austin, Robert E. Hawkins	303
2	Molecular analysis of single circulating tumour cells following long‐term storage of clinical samples 2017 ·Molecular Oncology ·Bárbara Mesquita, Dominic G. Rothwell, Deborah J. Burt, Francesca Chemi, Fabiola Fernández‐Gutiérrez, (unknown), Jenny Antonello, Mathew Carter, Louise Carter, Marina Parry, (unknown), Richard Marais, Fiona Blackhall, Caroline Dive, Ged Brady	7
3	Abstract 5685: An evaluation of DNA and RNA based blood biomarkers in prostate cancer 2017 ·Cancer Research ·Jenny Antonello, Jakub Chudziak, Alan Redfern, Victoria Foy, (unknown), Adnan Syed, Deborah J. Burt, Mahmood Ayub, Bedirhan Kilerci, Marina Parry, Richard Marais, Esther Baena, Crispin Miller, Dominic G. Rothwell, Noel W. Clarke, Caroline Dive, Ged Brady	1
4	Molecular analysis of circulating tumor cells identifies distinct copy-number profiles in patients with chemosensitive and chemorefractory small-cell lung cancer 2016 ·Nature Medicine ·Louise Carter, Dominic G. Rothwell, Bárbara Mesquita, Christopher Smowton, Hui Sun Leong, Fabiola Fernández‐Gutiérrez, Yaoyong Li, Deborah J. Burt, Jenny Antonello, Christopher J. Morrow, Cassandra L. Hodgkinson, Karen Morris, Lynsey Priest, Mathew Carter, Crispin Miller, Andrew Hughes, Fiona Blackhall, Caroline Dive, Ged Brady	239
5	Development of a circulating miRNA assay to monitor tumor burden: From mouse to man 2015 ·Molecular Oncology ·Alastair Greystoke, Mahmood Ayub, Dominic G. Rothwell, Dan Morris, Deborah J. Burt, Cassandra L. Hodgkinson, Christopher J. Morrow, Nigel Smith, (unknown), Juan Carlos del Valle, Louise Carter, Fiona Blackhall, Caroline Dive, Ged Brady	18
6	Expanded subpopulation of FoxP3+ T regulatory cells in renal cell carcinoma co-express Helios, indicating they could be derived from natural but not induced Tregs 2011 ·Clinical Immunology ·Eyad Elkord, Smita Sharma, Deborah J. Burt, Robert E. Hawkins	36
7	Circulating Regulatory T Cells in Endometrial Cancer: A Role for Age and Menopausal Status 2010 ·Immunological Investigations ·(unknown), Deborah J. Burt, Peter L. Stern, Cathrine Holland, Eyad Elkord	11
8	Tremelimumab (anti-CTLA4) mediates immune responses mainly by direct activation of T effector cells rather than by affecting T regulatory cells 2010 ·Clinical Immunology ·Sameena S. Khan, Deborah J. Burt, Christy Ralph, Fiona Thistlethwaite, Robert E. Hawkins, Eyad Elkord	57
9	Immune evasion mechanisms in colorectal cancer liver metastasis patients vaccinated with TroVax (MVA-5T4) 2009 ·Cancer Immunology Immunotherapy ·Eyad Elkord, Adam Dangoor, Deborah J. Burt, Thomas D. Southgate, Sai Daayana, Richard Harrop, Jan W. Drijfhout, David Sherlock, Robert E. Hawkins, Peter L. Stern	22
10	An MVA-based Vaccine Targeting the Oncofetal Antigen 5T4 in Patients Undergoing Surgical Resection of Colorectal Cancer Liver Metastases 2008 ·Journal of Immunotherapy ·Eyad Elkord, Adam Dangoor, Noel Drury, Richard Harrop, Deborah J. Burt, Jan W. Drijfhout, (unknown), (unknown), Stuart Naylor, David Sherlock, Robert E. Hawkins, Peter L. Stern	40
11	Adoptive transfer of Treg depleted autologous T cells in advanced renal cell carcinoma 2007 ·Cancer Immunology Immunotherapy ·Fiona Thistlethwaite, Eyad Elkord, Richard W. Griffiths, Deborah J. Burt, (unknown), John D. Campbell, David E. Gilham, Eric Austin, Peter L. Stern, Robert E. Hawkins	24
12	CD4+ T-cell recognition of human 5T4 oncofoetal antigen: implications for initial depletion of CD25+ T cells 2007 ·Cancer Immunology Immunotherapy ·Eyad Elkord, Deborah J. Burt, Jan W. Drijfhout, Robert E. Hawkins, Peter L. Stern	15
13	Cd8 T‐cell recognition of human 5T4 oncofetal antigen 2006 ·International Journal of Cancer ·Lucy J.C. Smyth, Eyad Elkord, Taher E.I. Taher, Hui‐Rong Jiang, Deborah J. Burt, Alison Clayton, Peter A. van Veelen, Arnoud de Ru, Ferry Ossendorp, Cornelis J.M. Melief, Jan W. Drijfhout, Said Dermime, Robert E. Hawkins, Peter L. Stern	20
14	A vaccinia-based vaccine (TroVax) targeting the oncofetal antigen 5T4 administered before and after surgical resection of colorectal cancer liver metastases: Phase II trial 2006 ·Journal of Clinical Oncology ·Adam Dangoor, Deborah J. Burt, Richard Harrop, Noel Drury, (unknown), (unknown), David Sherlock, Peter L. Stern, Robert D. Hawkins	7
15	Effect of TA-CIN (HPV 16 L2E6E7) booster immunisation in vulval intraepithelial neoplasia patients previously vaccinated with TA-HPV (vaccinia virus encoding HPV 16/18 E6E7) 2004 ·Vaccine ·Emma J. Davidson, (unknown), Peter Sehr, Michael Pawlita, Lucy J.C. Smyth, Deborah J. Burt, A. Tomlinson, Julian Hickling, HC Kitchener, Peter L. Stern	99
16	Human T cell responses to HPV 16 E2 generated with monocyte-derived dendritic cells 2001 ·International Journal of Cancer ·Emma J. Davidson, Michael D. Brown, Deborah J. Burt, Joanna L. Parish, Kevin Gaston, Henry C Kitchener, Simon Stacey, Peter L. Stern	13
17	Multiple mechanisms underlie HLA dysregulation in cervical cancer 2000 ·Tissue Antigens ·(unknown), Jennifer S. Bartholomew, Deborah J. Burt, (unknown), (unknown), Nick Telford, (unknown), (unknown), P. Jiménez, Francisco Ruiz‐Cabello, Federico Garrido, Peter L. Stern	109
18	Integration of high-risk human papillomavirus DNA is linked to the down-regulation of class I human leukocyte antigens by steroid hormones in cervical tumor cells. 1997 ·PubMed ·Jennifer S. Bartholomew, (unknown), Shubhashish Sarkar, Deborah J. Burt, M Stanley, Francisco Ruiz‐Cabello, (unknown), Federico Garrido, P L Stern	33
19	Identification of a naturally processed HLA A0201‐restricted viral peptide from cells expressing human papillomavirus type 16 E6 oncoprotein 1994 ·European Journal of Immunology ·Jennifer S. Bartholomew, Simon Stacey, Brian Coles, Deborah J. Burt, John R. Arrand, Peter L. Stern	33
20	Cellular immune recognition of HLA-G-expressing choriocarcinoma cell line JEG-3 1991 ·International Journal of Cancer ·Deborah J. Burt, (unknown), Tobias Rinke de Wit, Peter J. van den Elsen, Peter L. Stern	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact